![Mathew David](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mathew David
Finansdirektör/CFO på
ACTINIUM PHARMACEUTICALS, INC.
Förmögenhet: 280 000 $ per 2026-09-30
Profil
Dr. Mathew T.
David, MD, is a Chief Financial Officer at Actinium Pharmaceuticals, Inc. Dr. David was previously employed as a Chief Business Officer & Executive Vice President by CorMedix, Inc. and a Head-Strategy by Ovid Therapeutics, Inc. He received his undergraduate degree from Dartmouth College and a doctorate degree from New York University School of Medicine.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-10-14 | 250 000 ( 0,8 % ) | 280 000 $ | 2026-09-30 |
Aktiva positioner av Mathew David
| Företag | Position | Start |
|---|---|---|
| ACTINIUM PHARMACEUTICALS, INC. | Finansdirektör/CFO | 2026-10-14 |
Tidigare kända positioner av Mathew David
| Företag | Position | Slut |
|---|---|---|
| OVID THERAPEUTICS INC. | Företagsledare/Principal | - |
| CORMEDIX INC. | Verkställande Direktör | 2022-05-10 |
Mathew Davids utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
15
Första gradens relationer
5
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 5 |
|---|---|
CorMedix, Inc.
 CorMedix, Inc. BiotechnologyHealth Technology Develops medical devices for cardiovascular and kidney diseases | Health Technology |
Ovid Therapeutics, Inc.
 Ovid Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Provides medicines to children and adults with neurological disorders | Health Technology |
Dartmouth College
 Dartmouth College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Actinium Pharmaceuticals, Inc.
 Actinium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company developing targeted payload immunotherapeutic for the treatment of advanced cancers | Health Technology |
New York University School of Medicine
 New York University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
